Novel Oral miR-124 Enhancer Improves Remission in Refractory UC



(MedPage Today) — PHOENIX — A first-in-class oral miR-124 enhancer significantly improved clinical remission and endoscopic outcomes for patients with moderately to severely active ulcerative colitis (UC) who had failed multiple prior therapies…



Source link : https://www.medpagetoday.com/meetingcoverage/acg/118244

Author :

Publish date : 2025-10-30 20:24:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version